Stockreport

MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit

MIRA Pharmaceuticals, Inc.  (MIRA) 
PDF BALTIMORE, Aug. 31, 2023 /PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the [Read more]